SARS
Studies from the People's Republic of China and Taiwan advance knowledge in SARS research
Published in Gene Therapy Weekly, June 15th, 2006
Study 1: Researchers from the People's Republic of China have reported that severe acute respiratory syndrome (SARS)-CoV immunity is induced by a novel CpG oligodeoxynucleotide (CpG ODN).
"To develop CpG ODNs based therapy for prevention and treatment of SARS, we selected a novel CpG ODN (BW001), which displays B-type CpG ODN structure feature at the 5' and A-type CpG ODN structure feature at the 3' and tested for its anti-SARS-CoV activity," wrote M.S. Bao and colleagues of Jilin University.
"We found that the supernatants of human PBMCs...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-06-15)
More Articles from Gene Therapy Weekly
- Developmental Biology
Integrin maturation promoted by beta 1,4-galactosyltransferase down-regulation - Developmental Biology
Neurotrophic factor is required for developmental plasticity - Drug Delivery
Antisense peptide nucleic acid delivery involves basic amphipathic peptides - Gene Research
Canine X-linked severe combined immunodeficiency was corrected by gene therapy - Sickle Cell Anemia
Sickle cell gene specifically silenced by a single nucleotide polymorphism - Adenoviral Gene Therapy
Adenovirus-mediated gene expression is improved by a polyethylene glycol vehicle - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
